IMRA

Q: What is the price of Imara (IMRA) today?

The price of Imara (IMRA) today is R$ 198,19, with a variation of 0% compared to the last year. The price of Imara (IMRA) started the year trading around R$ 0,00 and today it is at R$ 198,19. Follow the real-time price chart, the historical price of Imara (IMRA), and stock data from Ibovespa and international markets.

Q: When does Imara (IMRA) pay dividends?

Imara (IMRA) did not distribute dividends in the last year.

Q: Imara (IMRA) is it worth it?

Currently, Imara (IMRA) is priced at R$ 198,19, with a P/E of 20,29%, representing a deviation of -1,57% from its historical average P/E. In the last year, the stock showed a variation of 0% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 50,76%. The total shareholder return was 0,00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Imara (IMRA)?

Investing in stocks of Imara (IMRA) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Imara (IMRA) yield today?

The yield of Imara (IMRA) was 1,91% in the last month, 0,00% in the last year and -39,85% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 96,94 in dividends, um Dividend Yield de 50,76%.If you wanted to buy 100 stocks of Imara (IMRA) today, the total investment would be R$ 19.819,03, based on the current price of R$ 198,19.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 19.819,03In 5 years: R$ 11.921,15In 10 years: 19.819,03It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Imara Inc.

Price

US$ 36,77

variation (12m)

0,00%

p/l

20,29

p/vp

2,59

DIVIDEND YIELD

50,76%

price IMRA

BVMF

IMRA

If you had invested

years ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of IMRA

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

1,91%

3 months

-8,12%

1 year

0,00%

2 years

0,00%

5 years

-39,85%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

1,91%

3 months

-8,26%

1 year

0,00%

2 years

0,00%

5 years

-55,72%

10 years

0,00%

Indicators IMRA

check out the fundamentals of Imara shares

P/E

20,29

Sector: -0,86 Industry: 18,80

P/SALES RATIO (PSR)

Sector: 1,91 Industry: 2,95

P/BV

2,59

Sector: 2,18 Industry: 3,24

DIVIDEND YIELD (DY)

50,76%

Sector: - Industry: -

ROA

12,52%

Sector: -26,75% Industry: -7,50%

ROE

12,78%

Sector: -29,56% Industry: -16,97%

ROIC

Sector: -411,55% Industry: -15,18%

NET MARGIN

0,00%

Sector: -27,20% Industry: -26,78%

GROSS MARGIN

0,00%

Sector: 43,14% Industry: 51,89%

OPERATING MARGIN

0,00%

Sector: -23,36% Industry: -20,40%

P/EBITDA

19,26

Sector: 0,46 Industry: 7,67

P/EBIT

20,41

Sector: -1,06 Industry: 6,72

P/ASSET

2,54

Sector: 1,22 Industry: 1,19

BVPS

13,66

Sector: 3,68 Industry: 8,92

EPS

1,75

Sector: -0,75 Industry: -0,02

EQUITY / ASSETS

0,98

Sector: 0,45 Industry: 0,45

CAGR REVENUES 5 YEARS

0,00%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

FAIR PRICE OF Imara ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 36,77

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-36,93%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

IMRA indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	49,21	37,01	75,21%	0,77%	US$ 679,14 B	25,91%
ISRG	62,05	9,34	15,04%	0,00%	US$ 167,60 B	28,29%
TMO	28,34	3,68	12,99%	0,33%	US$ 186,20 B	15,12%
SNY	7,20	1,41	19,52%	4,76%	US$ 113,97 B	22,40%
MDT	26,78	0,00	0,00%	3,02%	US$ 119,10 B	12,81%
CVS	17,09	1,20	7,05%	3,61%	US$ 93,41 B	1,40%
GSK	12,45	4,18	33,57%	4,01%	US$ 81,40 B	15,70%
ABT	16,54	4,55	27,50%	1,75%	US$ 231,23 B	32,43%
NVS	17,42	6,01	34,49%	2,98%	US$ 252,71 B	25,52%
TMDX	34,55	11,12	32,18%	0,00%	US$ 3,54 B	17,65%
BSX	55,99	7,01	12,51%	0,00%	US$ 158,69 B	14,65%
HCA	15,83	-81,23	-513,25%	0,66%	US$ 100,56 B	8,61%
INMD	6,11	1,50	24,58%	0,00%	US$ 943,74 M	42,09%
DHR	45,57	2,74	6,02%	0,59%	US$ 143,55 B	13,04%
IDXX	49,14	35,26	71,76%	0,00%	US$ 51,44 B	25,09%
FMS	19,30	0,88	4,56%	3,18%	US$ 14,54 B	3,48%
PHG	92,36	2,20	2,38%	3,17%	US$ 26,42 B	1,45%
HUM	22,70	2,04	8,97%	1,15%	US$ 37,26 B	1,30%
RMD	27,53	6,78	24,62%	0,77%	US$ 40,45 B	27,88%

comparison of IMRA with indexes

If you had invested (change) 2 years years ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history IMRA dividend history

current DY: 50,76%

5-year average DY: 50,76%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	22/08/2025	26/08/2025	2,90000000
Dividends	25/07/2025	29/07/2025	3,86500000
Dividends	27/06/2025	01/07/2025	1,89000000
Dividends	23/05/2025	28/05/2025	9,33000000

ABOUT THE COMPANY Imara

Imara Inc.

Average user rating I10

4.0 (0 people)

Estados Unidos

9 years

Foundation: 2016

2020

Year of debut on the stock exchange - 5 years

27

Employees

The Company Imara Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 233,71 Milhões, having a net worth of $ 90,13 Milhões.

With a total of 27 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ -, which generated a profit in the amount of $ 11,52 Milhões.

As for its main indicators, the Company has a P/E ratio of 20,29, a P/BV ratio of 2,59 and in the last 12 months the dividend yield of IMRA was at 50,76%.

The Company is traded internationally through the ticker IMRA.

Market value

US$ 233,71 Milhões

Net worth

US$ 90,13 Milhões

US$ 90.129.000,00

Assets

US$ 91,96 Milhões

US$ 91.959.000,00

Total Number of Shares

6,60 Milhões

6.596.000

Average Daily Trading Volume

US$ 15,34 Thousand

US$ 15.339,40

Sector

Health

Industry

Medical Supplies and Equipment

IMRA

IMRA revenue and profits

IMRA results

DRAG THE FRAME TO SEE MORE DATA

IMRA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 74,67 35,74% (12M)

P/L

17,09

3,61%

ROE

7,05%

P/VP

1,20

CI - Cigna

US$ 305,87 --13,60% (12M)

P/L

13,98

1,91%

ROE

14,37%

P/VP

2,01

CNC - Centene

US$ 34,08 --54,45% (12M)

P/L

13,16

0,00%

ROE

3,96%

P/VP

0,52

HUM - Humana

US$ 278,72 --12,71% (12M)

P/L

22,70

1,15%

ROE

8,97%

P/VP

2,04

SNY - Sanofi

US$ 47,65 --12,31% (12M)

P/L

7,20

4,76%

ROE

19,52%

P/VP

1,41

HCA - HCA Healthcare

US$ 402,85 3,09% (12M)

P/L

15,83

0,66%

ROE

-513,25%

P/VP

-81,23

LLY - Eli Lilly

US$ 756,28 --17,50% (12M)

P/L

49,21

0,77%

ROE

75,21%

P/VP

37,01

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 74,67 35,74% (12 M)

P/L

17,09

3,61%

ROE

7,05%

P/VP

1,20

CI - Cigna

US$ 305,87 --13,60% (12 M)

P/L

13,98

1,91%

ROE

14,37%

P/VP

2,01

CNC - Centene

US$ 34,08 --54,45% (12 M)

P/L

13,16

0,00%

ROE

3,96%

P/VP

0,52

HUM - Humana

US$ 278,72 --12,71% (12 M)

P/L

22,70

1,15%

ROE

8,97%

P/VP

2,04

SNY - Sanofi

US$ 47,65 --12,31% (12 M)

P/L

7,20

4,76%

ROE

19,52%

P/VP

1,41

HCA - HCA Healthcare

US$ 402,85 3,09% (12 M)

P/L

15,83

0,66%

ROE

-513,25%

P/VP

-81,23

LLY - Eli Lilly

US$ 756,28 --17,50% (12 M)

P/L

49,21

0,77%

ROE

75,21%

P/VP

37,01

Common Questions

What is the price of Imara (IMRA) today?

The price of Imara (IMRA) today is R$ 198,19, with a variation of 0% compared to the last year. The price of Imara (IMRA) started the year trading around R$ 0,00 and today it is at R$ 198,19. Follow the real-time price chart, the historical price of Imara (IMRA), and stock data from Ibovespa and international markets.

When does Imara (IMRA) pay dividends?

Imara (IMRA) did not distribute dividends in the last year.

Imara (IMRA) is it worth it?

Currently, Imara (IMRA) is priced at R$ 198,19, with a P/E of 20,29%, representing a deviation of -1,57% from its historical average P/E. In the last year, the stock showed a variation of 0% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 50,76%. The total shareholder return was 0,00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Imara (IMRA)?

Investing in stocks of Imara (IMRA) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Imara (IMRA) yield today?

The yield of Imara (IMRA) was 1,91% in the last month, 0,00% in the last year and -39,85% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 96,94 in dividends, um Dividend Yield de 50,76%.

If you wanted to buy 100 stocks of Imara (IMRA) today, the total investment would be R$ 19.819,03, based on the current price of R$ 198,19.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 19.819,03
In 5 years: R$ 11.921,15
In 10 years: 19.819,03

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

IMRA

Imara Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of IMRA

check out the fundamentals of Imara shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, today you would have

current DY: 50,76%

5-year average DY: 50,76%

type

date with

payment date

value

ABOUT THE COMPANY Imara

Imara Inc.

Estados Unidos

9 years

2020

27

IMRA results

IMRA cash flow

evolution of assets - IMRA

IMRA balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80